Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735.

Details

Language :

English

ISSN :

0732183X

Volume :

27

Issue :

8

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

105471857

Full Text :

https://doi.org/10.1200/JCO.2008.18.4028